Name Card
rp00362 picture

Professor Khoo, Ui Soon 邱瑋璇

Title:
Clinical Professor
Ada M.F. Chan Professor in Oncological Pathology

Department:
Department of Pathology

Faculty:
Li Ka Shing Faculty of Medicine

Principal Investigator
StatusProject CodeProject TitleAmountFunding Year
 
17113020Molecular mechanism of BQ323636.1, a novel splice variant of NCOR2 and its significance on treatment of estrogen receptor positive breast cancer.9962852020
 
07182026The synergistic effect of Ivabradine and Olaparib on triple negative breast cancer14921102019
 
06171916Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance12300942018
 
InP/025/17Testing Ivabradine On Patient Derived Xenografts: A Novel Potential Targeted Treatment For Breast Cancer3034972016
 
InP/010/18Testing Ivabradine On Patient Derived Xenografts: A Novel Potential Targeted Treatment For Breast Cancer1264402016
 
HKU 767307MSplicing variant profiling in relation to Estrogen Receptor gene expression in Chinese breast cancer8826272007
 
04050252Promoter polymorphisms of DC-SIGN in relation to host genetic susceptibility to SARS infection8049282005
 
HKU 7550/05MThe role of L-SIGN (CD290L) in SARS coronavirus infection7189572005
 
02040202Role of polymorphisms of the inflammatory response genes and DC-SIGNR in genetic susceptibility to SARS and other infections8050002004
 
N/AStudy of oncogenes in breast cancer01994
 
N/AThe role of oncogenes in the development and progression of breast carcinoma5540001995
 
HKU 7520/05MGene-based and haplotype analysis of the estrogen receptor genes for breast cancer susceptibility7189572005
 
21004458Infectious Diseases and Global Health: Genetic approach to the identification of host susceptibility factors and pathogen virulence determinants. Genetics of coronaviruses-associated acute respiratory disease7182372005
 
03040792The functional role of ICAM3 polymorphism in genetic susceptibility to SARS infection7979692005
 
210208HER2 FISH test to assess eligibility for transtuzumab (herceptin) in breast cancer patients applying for assistance from Samaritan Fund for treatment12085142010
 
ITS/015/13Development of Antibody Specific to Splice Variant of NCOR2 for the Management of Breast Cancer8998452013
 
InP/318/13Development of Antibody Specific to Splice Variant of NCOR2 for the Management of Breast Cancer2494252013
 
InP/321/13Development of Antibody Specific to Splice Variant of NCOR2 for the Management of Breast Cancer2117612013
 
213218HER2 Dual ISH test to assess eligibility for Trastuzumab (Herceptin) in breast cancer patients receiving treatment from public hospitals3196402013
 
N/ACharacterization of a Novel Splice Variant in Tamoxifen Resistant Breast Cancer11161802015
 
N/AGenetic polymorphism study of the immense response genes in relation to susceptibility, clinical outcome and treatment response of SARS750002003
 
04151826Hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) regulating apoptosis resistance, autophagy and cellular senescence in breast cancer: a novel potential anti-cancer target.11745772016
 
ITS/069/16Testing Ivabradine on Patient Derived Xenografts: A Novel Potential Targeted Treatment for Breast Cancer13299252016
Co-Investigator